Skip to content

H.R. 1512 · 118th Congress (2023–2025)

Greater Access to Contraceptive Options Act

This bill requires the Food and Drug Administration to prioritize review of supplemental applications for over-the counter, self-administered contraceptives (i.e., contraception that is administered without the intervention of a health care professional).

Show official title

To allow women greater access to a wider range of self-administered contraceptives approved under the Federal Food, Drug, and Cosmetic Act.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 1512’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Nancy Mace (R-SC-1)
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Mar 9, 2023 – Mar 17, 2023
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Mar 9, 2023
  2. HouseHealthReferred Mar 17, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Greater Access to Contraceptive Options Act

    Display title, Short title · Introduced in House

  2. To allow women greater access to a wider range of self-administered contraceptives approved under the Federal Food, Drug, and Cosmetic Act.

    Official title · Introduced in House